NOL4 Activators
NOL4 activators are a specific group of chemical compounds designed to enhance the activity of the nucleolar protein 4 (NOL4), which plays a significant role in the regulation of nucleolar functions, including ribosomal biogenesis and the processing of rRNA. These activators can directly interact with NOL4, inducing conformational changes that enhance its activity, or they may act indirectly by modulating the cellular environment to upregulate NOL4 expression or to facilitate its interaction with other proteins involved in nucleolar processes. The ultimate goal of employing NOL4 activators is to elucidate the biological pathways in which NOL4 is involved by observing the outcomes of its enhanced activity on cellular physiology. This can provide insights into the fundamental processes of cell biology, such as the synthesis of ribosomes, cell cycle regulation, and the stress response mechanisms of cells. The mechanism of action of NOL4 activators often involves the stabilization of NOL4 protein levels, enhancement of its binding affinity to nucleolar RNA, or the activation of signaling pathways that promote its nucleolar functions.
The discovery and characterization of NOL4 activators encompass various sophisticated techniques, starting from in silico screening methods to identify potential activators based on their chemical structure and predicted ability to interact with NOL4. Following the computational predictions, in vitro assays are conducted to test the efficacy of these compounds in activating NOL4. These assays may include enzyme-linked immunosorbent assays (ELISA), fluorescence resonance energy transfer (FRET) assays, and other biochemical tests to quantify the direct interaction between the activators and NOL4. Additionally, cellular assays are employed to observe the impact of NOL4 activation on nucleolar morphology, ribosomal RNA synthesis, and cell proliferation rates. Techniques such as confocal microscopy, quantitative PCR, and western blotting are utilized to assess changes in nucleolar structure, rRNA levels, and NOL4 protein levels, respectively.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
This compound could inhibit DNA methyltransferases, potentially leading to demethylation of the NOL4 promoter and increased expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
As an HDAC inhibitor, Vorinostat may relax chromatin structure near the NOL4 gene, facilitating transcriptional activation. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol may activate sirtuins and modulate p53 activity, which could influence NOL4 gene expression. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Sulforaphane might affect histone acetylation and methylation, potentially increasing NOL4 expression. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, a tyrosine kinase inhibitor, could modulate various signaling pathways, affecting NOL4 gene transcription. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin is known to affect numerous signaling pathways and could potentially upregulate NOL4 expression through epigenetic modifications. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate, an HDAC inhibitor, might enhance the transcription of genes like NOL4 by affecting chromatin structure. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
β-Estradiol can regulate gene expression by activating estrogen receptors that may bind to the NOL4 gene promoter. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid binds to retinoic acid receptors which can interact with the NOL4 promoter region to modulate its expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A binds to GC-rich DNA sequences, potentially affecting Sp1 transcription factor binding sites in the NOL4 promoter. | ||||||